Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UCB
2651
United Community Banks
UCB
$4.37B
| $2.38M | ﹤0.01% |
85,439
+49,918
| +141% | +$1.51M |
|
2652
Celestica
CLS
$42.1B
| $2.38M | ﹤0.01% |
219,844
+1,268
| +0.6% | +$15.2K |
|
|
AERI
2653
DELISTED
Aerie Pharmaceuticals
AERI
| $2.38M | ﹤0.01% |
38,675
+33,760
| +687% | +$2.17M |
|
2654
PUT
Travel + Leisure Co
TNL
$4.58B
| $2.38M | ﹤0.01% |
54,900
-1,900
| -3% | -$84.2K |
|
2655
PTC Therapeutics
PTCT
$6.19B
| $2.37M | ﹤0.01% |
50,432
+6,570
| +15% | +$272K |
|
2656
Safety Insurance
SAFT
$1.52B
| $2.37M | ﹤0.01% |
26,389
+12,016
| +84% | +$1.11M |
|
2657
CALL
Kinder Morgan
KMI
$70.7B
| $2.37M | ﹤0.01% |
133,400
-158,400
| -54% | -$2.83M |
|
2658
Meritage Homes
MTH
$4.77B
| $2.37M | ﹤0.01% |
118,552
+66,826
| +129% | +$1.46M |
|
2659
PUT
State Street SPDR S&P Homebuilders ETF
XHB
$1.59B
| $2.36M | ﹤0.01% |
61,500
+18,300
| +42% | +$731K |
|
2660
Casey's General Stores
CASY
$31B
| $2.36M | ﹤0.01% |
18,300
+5,862
| +47% | +$674K |
|
2661
Caleres
CAL
$463M
| $2.36M | ﹤0.01% |
65,878
+31,687
| +93% | +$1.14M |
|
2662
PUT
Huntsman Corp
HUN
$1.79B
| $2.36M | ﹤0.01% |
86,600
+3,800
| +5% | +$116K |
|
|
NP
2663
DELISTED
Neenah, Inc. Common Stock
NP
| $2.36M | ﹤0.01% |
27,328
+11,639
| +74% | +$1.04M |
|
2664
CALL
Tenet Healthcare
THC
$21.2B
| $2.36M | ﹤0.01% |
82,800
-353,200
| -81% | -$11.7M |
|
|
FITB
2665
CALL
Fifth Third Bancorp
FITB
$52.4B
| $2.35M | ﹤0.01% |
84,300
+8,700
| +12% | +$255K |
|
2666
Federated Hermes
FHI
$4.67B
| $2.35M | ﹤0.01% |
97,376
+73,448
| +307% | +$1.73M |
|
2667
Cathay General Bancorp
CATY
$4.3B
| $2.35M | ﹤0.01% |
56,576
+39,408
| +230% | +$1.65M |
|
2668
PUT
Textron
TXT
$15.1B
| $2.34M | ﹤0.01% |
32,800
-2,200
| -6% | -$150K |
|
2669
Walker & Dunlop
WD
$1.46B
| $2.34M | ﹤0.01% |
44,330
+29,700
| +203% | +$1.65M |
|
|
BPMC
2670
CALL
DELISTED
Blueprint Medicines
BPMC
| $2.34M | ﹤0.01% |
+30,000
| New | +$2.09M |
|
|
BPMC
2671
PUT
DELISTED
Blueprint Medicines
BPMC
| $2.34M | ﹤0.01% |
+30,000
| New | +$2.09M |
|
|
SAFM
2672
DELISTED
Sanderson Farms Inc
SAFM
| $2.34M | ﹤0.01% |
22,639
+11,156
| +97% | +$1.15M |
|
2673
Gerdau
GGB
$9.4B
| $2.34M | ﹤0.01% |
700,230
-82,262
| -11% | -$265K |
|
2674
Invesco Mortgage Capital
IVR
$805M
| $2.34M | ﹤0.01% |
14,797
+7,395
| +100% | +$1.2M |
|
|
MDP
2675
DELISTED
Meredith Corporation
MDP
| $2.34M | ﹤0.01% |
45,866
+25,089
| +121% | +$1.31M |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.